EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo

Zhenhai Zeng, Siheng Li, Xiuhong Ye, Yiran Wang, Qinmei Wang, Zhongxing Chen, Ziqian Wang, Jun Zhang, Qing Wang, Lu Chen, Shuangzhe Zhang, Zhilin Zou und 7 weitere

Advanced Science · 2024-07 · 11 (25)

DOI: 10.1002/advs.202401710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.04.2024. Verfasst von Zhenhai Zeng und 18 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Key Laboratory of Myopia, Chinese Academy of Medical Sciences, S…. Hauptthemen laut MEDLINE: Corneal Neovascularization, Gene Editing, Vascular Endothelial Growth Factor A, Disease Models, Animal. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology, EYE & ENT Hospital of Fudan University High-level Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal neovascularization (CNV) is a common clinical finding seen in a range of eye diseases. Current therapeutic approaches to treat corneal angiogenesis, in which vascular endothelial growth factor (VEGF) A plays a central role, can cause a variety of adverse side effects. The technology of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 can edit VEGFA gene to suppress its expression. CRISPR offers a novel opportunity to treat CNV. This study shows that depletion of VEGFA with a novel CRISPR/Cas9 system inhibits proliferation, migration, and tube formation of human umbilical vein endothelial cells (HUVECs) in vitro. Importantly, subconjunctival injection of this dual AAV‐SpCas9/sgRNA‐ VEGFA system is demonstrated which blocks suture‐induced expression of VEGFA, CD31, and α‐smooth muscle actin as well as corneal neovascularization in mice. This study has established a strong foundation for the treatment of corneal neovascularization via a gene editing approach for the first time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Corneal NeovascularizationGene EditingVascular Endothelial Growth Factor ADisease Models, AnimalHuman Umbilical Vein Endothelial CellsCRISPR-Cas SystemsAnimalsMiceHumansMice, Inbred C57BLCell Proliferation

Stichwörter der Autor:innen

(CRISPR)/Cas9CNVVEGFAgenome editing

Substanzen

Vascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200000, China.
  • Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200000, China.
  • School of Ophthalmology and Optometry and Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
  • Key Laboratory for Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, 510000, China.
  • Department of Ophthalmology, 2nd Affiliated Hospital of Nanchang University, Nanchang, 330000, China.
  • Corneo Plastic Unit & Eye Bank, Queen Victoria Hospital, East Grinstead, RH19 3AX, UK.

ORCID-Profile: Jinhai Huang

Förderung

  • National Natural Science Foundation of China
  • Shanghai Science and Technology
  • EYE & ENT Hospital of Fudan University High-level Talents Program
  • Project of Shanghai Xuhui District Science and Technology
  • Program for Professor of Special Appointment
  • Shanghai Institutions of Higher Learning
  • Medical Engineering fund of Fudan University

Zitieren

APA

Zeng, Z., Li, S., Ye, X., Wang, Y., Wang, Q., Chen, Z., Wang, Z., Zhang, J., Wang, Q., Chen, L., Zhang, S., Zou, Z., Lin, M., Chen, X., Zhao, G., McAlinden, C., Lei, H., Zhou, X., & Huang, J. (2024). Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo. Advanced Science, 11(25). https://doi.org/10.1002/advs.202401710

Vancouver

Zeng Z, Li S, Ye X, Wang Y, Wang Q, Chen Z, et al. Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo. Advanced Science. 2024;11(25). doi:10.1002/advs.202401710

BibTeX
@article{Zeng2024,
  author = {Zeng, Zhenhai and Li, Siheng and Ye, Xiuhong and Wang, Yiran and Wang, Qinmei and Chen, Zhongxing and Wang, Ziqian and Zhang, Jun and Wang, Qing and Chen, Lu and Zhang, Shuangzhe and Zou, Zhilin and Lin, Meimin and Chen, Xinyi and Zhao, Guoli and McAlinden, Colm and Lei, Hetian and Zhou, Xingtao and Huang, Jinhai},
  title = {Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {25},
  doi = {10.1002/advs.202401710}
}
Kostenlos starten →